Genentech Asks Hospitals to Check 340B Split-Billing Software Settings

Genentech building
Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Drug manufacturer Genentech has asked health systems and hospitals about possible 340B program compliance violations involving split-billing software settings. Staff [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds Drug to Hospital Contract Pharmacy Restriction Policy

Drugmaker Teva recently added its medication Austedo to its list of drugs under 340B contract pharmacy restrictions for hospitals.
Drug manufacturer Teva this week added a drug to the hospital contract pharmacy restrictions it first implemented in June. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

HHS signage and building
HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.
A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Rural Providers Urge Congress to Extend Pandemic-Era 340B Eligibility Exemptions

Tidelands Georgetown Memorial Hospital is part of a coalition of rural providers pushing Congress to extend a 2022 340B eligibility waiver.
More than 400 hospitals risk losing 340B eligibility if Congress does not extend exemptions authorized during the public health emergency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Most 340B DSH Hospitals Provide Below-Average Charity Care, Says Analysis Backed by Critics

Bob Dold, a spokesperson for AIR340B, said the 340B program "has not translated into a stronger safety-net” after a drug industry backed analysis found 340B DSH hospitals provide below-average charity care.
The majority of 340B disproportionate share hospitals (DSH) provide charity care at lower rates than the national hospital average, found [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Paper Warns on Duplicate Discounts from 340B Ceiling Price, Medicare Maximum Price

An Avalere study suggested 340B duplicate discounts could increase as a result of Medicare drug price negotiations.
Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eisai’s New 340B Contract Pharmacy Restrictions to Exclude Arkansas and Louisiana

Eisai contract pharmacy
Drugmaker Eisai's 340B hospital contract pharmacy restrictions will not apply to Arkansas and Louisiana providers.
Japanese pharmaceutical manufacturer Eisai will not limit hospital 340B contract pharmacy use in Arkansas and Louisiana after its new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New BMS Contract Pharmacy Policy May Target Hospital Self-Distribution, Say Attorneys

Bill Von Oehsen
William von Oehsen, principal at the law firm Powers, said the SUSTAIN ACT is "not going to live or die based on the user fee."
Drugmaker Bristol Myers Squibb added new language to its latest 340B contract pharmacy policy notice, which appears to target hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Following Response Deadline, Next Steps in Senator’s 340B Probe Unclear

Bill Cassidy
Sen. Bill Cassidy, ranking Republican on the Senate HELP Committee, does not appear to have the authority to compel hospitals to respond to his inquiry on 340B revenue.
The deadline has passed for two health systems to respond to an influential senator’s probe into 340B revenue, and at [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Says 340B Lump Sum Payments Fueled Increase in Part B Premiums, Deductibles

CMS building
CMS said planned Medicare Part B premium increases are partly the result of the proposed lump sum payment for previous illegal 340B hospital cuts.
Federal regulators recently said planned out-of-pocket increases for Medicare beneficiaries are due, in part, to the proposed lump sum payment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live